Herpes simplex virus spreads rapidly in human foreskin, partly driven by chemokine-induced redistribution of Nectin-1 on keratinocytes.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 22 11 2023
accepted: 17 05 2024
medline: 10 6 2024
pubmed: 10 6 2024
entrez: 10 6 2024
Statut: epublish

Résumé

HSV infects keratinocytes in the epidermis of skin via nectin-1. We established a human foreskin explant infection model to investigate HSV entry and spread. HSV1 entry could only be achieved by the topical application of virus via high density microarray projections (HD-MAPs) to the epidermis, which penetrated beyond one third of its thickness, simulating in vivo microtrauma. Rapid lateral spread of HSV1 to a mean of 13 keratinocytes wide occurred after 24 hours and free virus particles were observed between keratinocytes, consistent with an intercellular route of spread. Nectin-1 staining was markedly decreased in foci of infection in the epidermis and in the human keratinocyte HaCaT cell line. Nectin-1 was redistributed, at the protein level, in adjacent uninfected cells surrounding infection, inducible by CCL3, IL-8 (or CXCL8), and possibly CXCL10 and IL-6, thus facilitating spread. These findings provide the first insights into HSV1 entry and spread in human inner foreskin in situ.

Identifiants

pubmed: 38857290
doi: 10.1371/journal.ppat.1012267
pii: PPATHOGENS-D-23-02057
doi:

Substances chimiques

Nectins 0
NECTIN1 protein, human 0
Chemokines 0
Cell Adhesion Molecules 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1012267

Informations de copyright

Copyright: © 2024 Rana et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Hafsa Rana (H)

The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Naomi R Truong (NR)

The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Blake Johnson (B)

The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Heeva Baharlou (H)

The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Jason J Herbert (JJ)

The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Sasikaran Kandasamy (S)

Research and Development, Vaxxas Pty Ltd., Brisbane, Queensland, Australia.

Robert Goddard (R)

Research and Development, Vaxxas Pty Ltd., Brisbane, Queensland, Australia.

Ralph C Cohen (RC)

University of Sydney and Australian National University, Children's Hospital at Westmead, New South Wales, Australia.

Michael Wines (M)

Urology, Sydney Adventist Hospital, Wahroonga, New South Wales, Australia.

Najla Nasr (N)

The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Andrew N Harman (AN)

The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Kirstie M Bertram (KM)

The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Kerrie J Sandgren (KJ)

The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Anthony L Cunningham (AL)

The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH